Status:
COMPLETED
The Role of Fatty Acids in Vaccine Efficacy
Lead Sponsor:
Tsinghua University
Conditions:
Rabies Vaccination Reaction
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This study intends to use a randomized controlled trial design to vaccinate all participants against rabies and perform ARA interventions during vaccination to test the efficacy, safety, and intestina...
Detailed Description
Rabies is an acute zoonotic infectious disease caused by central nervous system invasion by rabies virus. At present, there is still a lack of effective treatment, and once clinical symptoms appear, i...
Eligibility Criteria
Inclusion
- 1）18-45 years old;
- 2）BMI 18.5-24.9 kg/m2;
- 3）Have not received rabies vaccination.
Exclusion
- 1\) Those who have severe disorders of abnormal lipid metabolism;
- 2\) Those who have used lipid-lowering drugs, weight loss drugs, and insulin drugs in the past three months;
- 3\) Those who have received other vaccines in the past three months;
- 4\) Those who have used probiotics or prebiotics in the past three months;
- 5\) Those who have used steroids and immunosuppressants, other hormonal drugs in the past year;
- 6\) Those with immunodeficiency diseases;
- 7\) Those with a history of severe vaccine allergies;
- 8\) Those who have disorders of liver and kidney metabolism;
- 9\) Those who have had fever, cold, severe diarrhea and other diseases in the past month.
- 10\) Smokers in the last year.
Key Trial Info
Start Date :
May 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05987384
Start Date
May 3 2023
End Date
July 30 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tsinghua University
Beijing, Beijing Municipality, China, 100084